Emcure Pharma Board Sees Director Retirement and Reappointments

Emcure Pharmaceuticals Ltd announced changes in its Board composition following its 45th Annual General Meeting (AGM) held on September 21, 2026. Mr. Berjis Desai retired as Chairman and Non-Executive Non-Independent Director. The members also approved the re-appointment of Dr. Mukund Gurjar as Whole-time Director for one year from August 28, 2026, and Mr. Satish Mehta as Managing Director & CEO for five years from April 1, 2027. Additionally, Mr. Raghu Kumar was appointed as an Independent Director for a three-year term effective August 6, 2026. Voting results were submitted to stock exchanges on September 23, 2026.